 | • レポートコード：MRC2-11QY12458 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はカポジ肉腫（KS）のグローバル市場について調査・分析したレポートです。種類別（クラシック、風土病、免疫抑制療法関連、エピデミック）市場規模、用途別（病院、がん研究機関、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別カポジ肉腫（KS）の競争状況、市場シェア ・世界のカポジ肉腫（KS）市場：種類別市場規模 2015年-2020年（クラシック、風土病、免疫抑制療法関連、エピデミック） ・世界のカポジ肉腫（KS）市場：種類別市場規模予測 2021年-2026年（クラシック、風土病、免疫抑制療法関連、エピデミック） ・世界のカポジ肉腫（KS）市場：用途別市場規模 2015年-2020年（病院、がん研究機関、クリニック） ・世界のカポジ肉腫（KS）市場：用途別市場規模予測 2021年-2026年（病院、がん研究機関、クリニック） ・北米のカポジ肉腫（KS）市場分析：米国、カナダ ・ヨーロッパのカポジ肉腫（KS）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのカポジ肉腫（KS）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のカポジ肉腫（KS）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのカポジ肉腫（KS）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Aphios、Bristol Myers Squibb、Cytori Therapeutics、CytRx、Eli Lilly and Company、GlaxoSmithKline、Roche、Johnson and Johnson、Merck、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Kaposi’s sarcoma (KS) is a type of cancer that can form masses in the skin, lymph nodes, or other organs. The skin lesions are usually purplein color. They can occur singularly, in a limited area, or be widespread. It may worsen either gradually or quickly. Lesions may be flat or raised.
Four sub-types are described: classic, endemic, immunosuppresion therapy-related, and epidemic. Classic KS tends to affect older men, be slow growing, and affect the legs. Endemic KS occurs in young adult males in Africa and can be more aggressive. Immunosuppresion therapy-related KS generally occurs in people following organ transplantation and mostly affects the skin. Epidemic KS occurs in people with AIDS and many parts of the body can be affected. The diagnosis is by tissue biopsy while the extent of disease may be determined by medical imaging.
Market Analysis and Insights: Global Kaposi Sarcoma Market
The global Kaposi Sarcoma market size is projected to reach US$ 107 million by 2026, from US$ 105 million in 2020, at a CAGR of 1.8%% during 2021-2026.
Global Kaposi Sarcoma Scope and Market Size
Kaposi Sarcoma market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Kaposi Sarcoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Aphios
Bristol Myers Squibb
Cytori Therapeutics
CytRx
Eli Lilly and Company
GlaxoSmithKline
Roche
Johnson and Johnson
Merck
Pfizer
Market segment by Type, the product can be split into
Classic
Endemic
Immunosuppresion Therapy-Related
Epidemic
Market segment by Application, split into
Hospital
Cancer Research Institution
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Kaposi Sarcoma Revenue
1.4 Market by Type
1.4.1 Global Kaposi Sarcoma Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Classic
1.4.3 Endemic
1.4.4 Immunosuppresion Therapy-Related
1.4.5 Epidemic
1.5 Market by Application
1.5.1 Global Kaposi Sarcoma Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Cancer Research Institution
1.5.4 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Kaposi Sarcoma Market Perspective (2015-2026)
2.2 Global Kaposi Sarcoma Growth Trends by Regions
2.2.1 Kaposi Sarcoma Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Kaposi Sarcoma Historic Market Share by Regions (2015-2020)
2.2.3 Kaposi Sarcoma Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Kaposi Sarcoma Market Growth Strategy
2.3.6 Primary Interviews with Key Kaposi Sarcoma Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Kaposi Sarcoma Players by Market Size
3.1.1 Global Top Kaposi Sarcoma Players by Revenue (2015-2020)
3.1.2 Global Kaposi Sarcoma Revenue Market Share by Players (2015-2020)
3.1.3 Global Kaposi Sarcoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Kaposi Sarcoma Market Concentration Ratio
3.2.1 Global Kaposi Sarcoma Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Kaposi Sarcoma Revenue in 2019
3.3 Kaposi Sarcoma Key Players Head office and Area Served
3.4 Key Players Kaposi Sarcoma Product Solution and Service
3.5 Date of Enter into Kaposi Sarcoma Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Kaposi Sarcoma Historic Market Size by Type (2015-2020)
4.2 Global Kaposi Sarcoma Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Kaposi Sarcoma Market Size by Application (2015-2020)
5.2 Global Kaposi Sarcoma Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Kaposi Sarcoma Market Size (2015-2020)
6.2 Kaposi Sarcoma Key Players in North America (2019-2020)
6.3 North America Kaposi Sarcoma Market Size by Type (2015-2020)
6.4 North America Kaposi Sarcoma Market Size by Application (2015-2020)
7 Europe
7.1 Europe Kaposi Sarcoma Market Size (2015-2020)
7.2 Kaposi Sarcoma Key Players in Europe (2019-2020)
7.3 Europe Kaposi Sarcoma Market Size by Type (2015-2020)
7.4 Europe Kaposi Sarcoma Market Size by Application (2015-2020)
8 China
8.1 China Kaposi Sarcoma Market Size (2015-2020)
8.2 Kaposi Sarcoma Key Players in China (2019-2020)
8.3 China Kaposi Sarcoma Market Size by Type (2015-2020)
8.4 China Kaposi Sarcoma Market Size by Application (2015-2020)
9 Japan
9.1 Japan Kaposi Sarcoma Market Size (2015-2020)
9.2 Kaposi Sarcoma Key Players in Japan (2019-2020)
9.3 Japan Kaposi Sarcoma Market Size by Type (2015-2020)
9.4 Japan Kaposi Sarcoma Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Kaposi Sarcoma Market Size (2015-2020)
10.2 Kaposi Sarcoma Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Kaposi Sarcoma Market Size by Type (2015-2020)
10.4 Southeast Asia Kaposi Sarcoma Market Size by Application (2015-2020)
11 India
11.1 India Kaposi Sarcoma Market Size (2015-2020)
11.2 Kaposi Sarcoma Key Players in India (2019-2020)
11.3 India Kaposi Sarcoma Market Size by Type (2015-2020)
11.4 India Kaposi Sarcoma Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Kaposi Sarcoma Market Size (2015-2020)
12.2 Kaposi Sarcoma Key Players in Central & South America (2019-2020)
12.3 Central & South America Kaposi Sarcoma Market Size by Type (2015-2020)
12.4 Central & South America Kaposi Sarcoma Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Aphios
13.1.1 Aphios Company Details
13.1.2 Aphios Business Overview
13.1.3 Aphios Kaposi Sarcoma Introduction
13.1.4 Aphios Revenue in Kaposi Sarcoma Business (2015-2020))
13.1.5 Aphios Recent Development
13.2 Bristol Myers Squibb
13.2.1 Bristol Myers Squibb Company Details
13.2.2 Bristol Myers Squibb Business Overview
13.2.3 Bristol Myers Squibb Kaposi Sarcoma Introduction
13.2.4 Bristol Myers Squibb Revenue in Kaposi Sarcoma Business (2015-2020)
13.2.5 Bristol Myers Squibb Recent Development
13.3 Cytori Therapeutics
13.3.1 Cytori Therapeutics Company Details
13.3.2 Cytori Therapeutics Business Overview
13.3.3 Cytori Therapeutics Kaposi Sarcoma Introduction
13.3.4 Cytori Therapeutics Revenue in Kaposi Sarcoma Business (2015-2020)
13.3.5 Cytori Therapeutics Recent Development
13.4 CytRx
13.4.1 CytRx Company Details
13.4.2 CytRx Business Overview
13.4.3 CytRx Kaposi Sarcoma Introduction
13.4.4 CytRx Revenue in Kaposi Sarcoma Business (2015-2020)
13.4.5 CytRx Recent Development
13.5 Eli Lilly and Company
13.5.1 Eli Lilly and Company Company Details
13.5.2 Eli Lilly and Company Business Overview
13.5.3 Eli Lilly and Company Kaposi Sarcoma Introduction
13.5.4 Eli Lilly and Company Revenue in Kaposi Sarcoma Business (2015-2020)
13.5.5 Eli Lilly and Company Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview
13.6.3 GlaxoSmithKline Kaposi Sarcoma Introduction
13.6.4 GlaxoSmithKline Revenue in Kaposi Sarcoma Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Roche
13.7.1 Roche Company Details
13.7.2 Roche Business Overview
13.7.3 Roche Kaposi Sarcoma Introduction
13.7.4 Roche Revenue in Kaposi Sarcoma Business (2015-2020)
13.7.5 Roche Recent Development
13.8 Johnson and Johnson
13.8.1 Johnson and Johnson Company Details
13.8.2 Johnson and Johnson Business Overview
13.8.3 Johnson and Johnson Kaposi Sarcoma Introduction
13.8.4 Johnson and Johnson Revenue in Kaposi Sarcoma Business (2015-2020)
13.8.5 Johnson and Johnson Recent Development
13.9 Merck
13.9.1 Merck Company Details
13.9.2 Merck Business Overview
13.9.3 Merck Kaposi Sarcoma Introduction
13.9.4 Merck Revenue in Kaposi Sarcoma Business (2015-2020)
13.9.5 Merck Recent Development
13.10 Pfizer
13.10.1 Pfizer Company Details
13.10.2 Pfizer Business Overview
13.10.3 Pfizer Kaposi Sarcoma Introduction
13.10.4 Pfizer Revenue in Kaposi Sarcoma Business (2015-2020)
13.10.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Kaposi Sarcoma Key Market Segments
Table 2. Key Players Covered: Ranking by Kaposi Sarcoma Revenue
Table 3. Ranking of Global Top Kaposi Sarcoma Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Kaposi Sarcoma Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Classic
Table 6. Key Players of Endemic
Table 7. Key Players of Immunosuppresion Therapy-Related
Table 8. Key Players of Epidemic
Table 9. Global Kaposi Sarcoma Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Kaposi Sarcoma Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Kaposi Sarcoma Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Kaposi Sarcoma Market Share by Regions (2015-2020)
Table 13. Global Kaposi Sarcoma Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Kaposi Sarcoma Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Kaposi Sarcoma Market Growth Strategy
Table 19. Main Points Interviewed from Key Kaposi Sarcoma Players
Table 20. Global Kaposi Sarcoma Revenue by Players (2015-2020) (Million US$)
Table 21. Global Kaposi Sarcoma Market Share by Players (2015-2020)
Table 22. Global Top Kaposi Sarcoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kaposi Sarcoma as of 2019)
Table 23. Global Kaposi Sarcoma by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Kaposi Sarcoma Product Solution and Service
Table 26. Date of Enter into Kaposi Sarcoma Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Kaposi Sarcoma Market Size by Type (2015-2020) (Million US$)
Table 29. Global Kaposi Sarcoma Market Size Share by Type (2015-2020)
Table 30. Global Kaposi Sarcoma Revenue Market Share by Type (2021-2026)
Table 31. Global Kaposi Sarcoma Market Size Share by Application (2015-2020)
Table 32. Global Kaposi Sarcoma Market Size by Application (2015-2020) (Million US$)
Table 33. Global Kaposi Sarcoma Market Size Share by Application (2021-2026)
Table 34. North America Key Players Kaposi Sarcoma Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Kaposi Sarcoma Market Share (2019-2020)
Table 36. North America Kaposi Sarcoma Market Size by Type (2015-2020) (Million US$)
Table 37. North America Kaposi Sarcoma Market Share by Type (2015-2020)
Table 38. North America Kaposi Sarcoma Market Size by Application (2015-2020) (Million US$)
Table 39. North America Kaposi Sarcoma Market Share by Application (2015-2020)
Table 40. Europe Key Players Kaposi Sarcoma Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Kaposi Sarcoma Market Share (2019-2020)
Table 42. Europe Kaposi Sarcoma Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Kaposi Sarcoma Market Share by Type (2015-2020)
Table 44. Europe Kaposi Sarcoma Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Kaposi Sarcoma Market Share by Application (2015-2020)
Table 46. China Key Players Kaposi Sarcoma Revenue (2019-2020) (Million US$)
Table 47. China Key Players Kaposi Sarcoma Market Share (2019-2020)
Table 48. China Kaposi Sarcoma Market Size by Type (2015-2020) (Million US$)
Table 49. China Kaposi Sarcoma Market Share by Type (2015-2020)
Table 50. China Kaposi Sarcoma Market Size by Application (2015-2020) (Million US$)
Table 51. China Kaposi Sarcoma Market Share by Application (2015-2020)
Table 52. Japan Key Players Kaposi Sarcoma Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Kaposi Sarcoma Market Share (2019-2020)
Table 54. Japan Kaposi Sarcoma Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Kaposi Sarcoma Market Share by Type (2015-2020)
Table 56. Japan Kaposi Sarcoma Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Kaposi Sarcoma Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Kaposi Sarcoma Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Kaposi Sarcoma Market Share (2019-2020)
Table 60. Southeast Asia Kaposi Sarcoma Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Kaposi Sarcoma Market Share by Type (2015-2020)
Table 62. Southeast Asia Kaposi Sarcoma Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Kaposi Sarcoma Market Share by Application (2015-2020)
Table 64. India Key Players Kaposi Sarcoma Revenue (2019-2020) (Million US$)
Table 65. India Key Players Kaposi Sarcoma Market Share (2019-2020)
Table 66. India Kaposi Sarcoma Market Size by Type (2015-2020) (Million US$)
Table 67. India Kaposi Sarcoma Market Share by Type (2015-2020)
Table 68. India Kaposi Sarcoma Market Size by Application (2015-2020) (Million US$)
Table 69. India Kaposi Sarcoma Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Kaposi Sarcoma Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Kaposi Sarcoma Market Share (2019-2020)
Table 72. Central & South America Kaposi Sarcoma Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Kaposi Sarcoma Market Share by Type (2015-2020)
Table 74. Central & South America Kaposi Sarcoma Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Kaposi Sarcoma Market Share by Application (2015-2020)
Table 76. Aphios Company Details
Table 77. Aphios Business Overview
Table 78. Aphios Product
Table 79. Aphios Revenue in Kaposi Sarcoma Business (2015-2020) (Million US$)
Table 80. Aphios Recent Development
Table 81. Bristol Myers Squibb Company Details
Table 82. Bristol Myers Squibb Business Overview
Table 83. Bristol Myers Squibb Product
Table 84. Bristol Myers Squibb Revenue in Kaposi Sarcoma Business (2015-2020) (Million US$)
Table 85. Bristol Myers Squibb Recent Development
Table 86. Cytori Therapeutics Company Details
Table 87. Cytori Therapeutics Business Overview
Table 88. Cytori Therapeutics Product
Table 89. Cytori Therapeutics Revenue in Kaposi Sarcoma Business (2015-2020) (Million US$)
Table 90. Cytori Therapeutics Recent Development
Table 91. CytRx Company Details
Table 92. CytRx Business Overview
Table 93. CytRx Product
Table 94. CytRx Revenue in Kaposi Sarcoma Business (2015-2020) (Million US$)
Table 95. CytRx Recent Development
Table 96. Eli Lilly and Company Company Details
Table 97. Eli Lilly and Company Business Overview
Table 98. Eli Lilly and Company Product
Table 99. Eli Lilly and Company Revenue in Kaposi Sarcoma Business (2015-2020) (Million US$)
Table 100. Eli Lilly and Company Recent Development
Table 101. GlaxoSmithKline Company Details
Table 102. GlaxoSmithKline Business Overview
Table 103. GlaxoSmithKline Product
Table 104. GlaxoSmithKline Revenue in Kaposi Sarcoma Business (2015-2020) (Million US$)
Table 105. GlaxoSmithKline Recent Development
Table 106. Roche Company Details
Table 107. Roche Business Overview
Table 108. Roche Product
Table 109. Roche Revenue in Kaposi Sarcoma Business (2015-2020) (Million US$)
Table 110. Roche Recent Development
Table 111. Johnson and Johnson Business Overview
Table 112. Johnson and Johnson Product
Table 113. Johnson and Johnson Company Details
Table 114. Johnson and Johnson Revenue in Kaposi Sarcoma Business (2015-2020) (Million US$)
Table 115. Johnson and Johnson Recent Development
Table 116. Merck Company Details
Table 117. Merck Business Overview
Table 118. Merck Product
Table 119. Merck Revenue in Kaposi Sarcoma Business (2015-2020) (Million US$)
Table 120. Merck Recent Development
Table 121. Pfizer Company Details
Table 122. Pfizer Business Overview
Table 123. Pfizer Product
Table 124. Pfizer Revenue in Kaposi Sarcoma Business (2015-2020) (Million US$)
Table 125. Pfizer Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kaposi Sarcoma Market Share by Type: 2020 VS 2026
Figure 2. Classic Features
Figure 3. Endemic Features
Figure 4. Immunosuppresion Therapy-Related Features
Figure 5. Epidemic Features
Figure 6. Global Kaposi Sarcoma Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Cancer Research Institution Case Studies
Figure 9. Clinics Case Studies
Figure 10. Kaposi Sarcoma Report Years Considered
Figure 11. Global Kaposi Sarcoma Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Kaposi Sarcoma Market Share by Regions: 2020 VS 2026
Figure 13. Global Kaposi Sarcoma Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Kaposi Sarcoma Market Share by Players in 2019
Figure 16. Global Top Kaposi Sarcoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kaposi Sarcoma as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Kaposi Sarcoma Revenue in 2019
Figure 18. North America Kaposi Sarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Kaposi Sarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Kaposi Sarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Kaposi Sarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Kaposi Sarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Kaposi Sarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Kaposi Sarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
軟部肉腫治療の世界市場（～2026年） Sarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. Increasing cases of soft tissue sarcoma and different types of cancer are expected to boost the growth for soft tissue sarcoma market. Market Analysis and Insights: Global So…- 滑膜肉腫治療の世界市場（～2026年） Market Analysis and Insights: Global Synovial Sarcoma Treatment Market The global Synovial Sarcoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Synovial Sarcoma Treatment Scope and Market Size Synovial Sar…
- エイズ（HIV）関連がんの世界市場（～2026年） The cancers occurring most commonly in the patients infected with human immunodeficiency virus (HIV) are referred to as AIDS related cancers. Kaposi sarcoma, cervical cancer and non-Hodgkin lymphoma are some of the most common AIDS related cancers. Cancers of throat, lungs, colon, skin, rectum, mout…
- がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…
- 膵臓がん治療の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …